CDK2AP1 Antikörper (AA 1-115) (HRP)
Kurzübersicht für CDK2AP1 Antikörper (AA 1-115) (HRP) (ABIN7148872)
Target
Alle CDK2AP1 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- AA 1-115
-
Kreuzreaktivität
- Human
-
Aufreinigung
- >95%, Protein G purified
-
Immunogen
- Recombinant Human Cyclin-dependent kinase 2-associated protein 1 protein (1-115AA)
-
Isotyp
- IgG
-
-
-
-
Applikationshinweise
- Optimal working dilution should be determined by the investigator.
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Buffer
-
Preservative: 0.03 % Proclin 300
Constituents: 50 % Glycerol, 0.01M PBS, PH 7.4 -
Konservierungsmittel
- ProClin
-
Vorsichtsmaßnahmen
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Lagerung
- -20 °C,-80 °C
-
Informationen zur Lagerung
- Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
-
-
- CDK2AP1 (Cyclin-Dependent Kinase 2 Associated Protein 1 (CDK2AP1))
-
Andere Bezeichnung
- CDK2AP1
-
Hintergrund
-
Background: specific inhibitor of the cell-cycle kinase CDK2
Aliases: CDK2 A1 antibody, CDK2 associated protein 1 antibody, CDK2-associated protein 1 antibody, CDK2AP1 antibody, CDKA1 antibody, CDKA1_HUMAN antibody, Cyclin dependent kinase 2 associated protein 1 antibody, Cyclin-dependent kinase 2-associated protein 1 antibody, Deleted in oral cancer 1 antibody, DOC 1 antibody, DOC 1 related protein antibody, DOC 1R antibody, DOC-1 antibody, DOC1 antibody, DOC1R antibody, DORC1 antibody, p12DOC 1 antibody, Putative oral cancer suppressor antibody, ST19 antibody
-
UniProt
- O14519
Target
-